title: Superimposed linear psoriasis: low effectiveness of biologic therapy.
authors.forename: L
authors.initials: L
authors.lastname: Colombo
authors.forename: M
authors.initials: M
authors.lastname: Marconi
authors.forename: E T M
authors.initials: ET
authors.lastname: Mapelli
authors.forename: E
authors.initials: E
authors.lastname: Crespi
authors.forename: L
authors.initials: L
authors.lastname: Gualandri
authors.forename: S
authors.initials: S
authors.lastname: Menni
authors.forename: A
authors.initials: A
authors.lastname: Cerri
mesh_terms: D017255:Acitretin / Q000627:therapeutic use; D000368:Aged; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D015535:Arthritis, Psoriatic / Q000188:drug therapy / Q000235:genetics; D001691:Biological Therapy; D016572:Cyclosporine / Q000627:therapeutic use; D000068800:Etanercept; D006801:Humans; D007074:Immunoglobulin G / Q000627:therapeutic use*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D019656:Loss of Heterozygosity; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use; D011565:Psoriasis / Q000145:classification / Q000188:drug therapy* / Q000235:genetics / Q000473:pathology; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use*
chemical_list: D018501:Antirheumatic Agents; D007074:Immunoglobulin G; D007166:Immunosuppressive Agents; D018124:Receptors, Tumor Necrosis Factor; D016572:Cyclosporine; D017255:Acitretin; D000068800:Etanercept; D008727:Methotrexate